Adherence to dietary prescriptions in patients with acute food protein-induced enterocolitis syndrome.
Adherence
Dietary management
Follow up
Food protein‐induced enterocolitis syndrome
Journal
Pediatric investigation
ISSN: 2574-2272
Titre abrégé: Pediatr Investig
Pays: United States
ID NLM: 101731527
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
21
01
2022
accepted:
17
05
2022
entrez:
7
10
2022
pubmed:
8
10
2022
medline:
8
10
2022
Statut:
epublish
Résumé
Food protein-induced enterocolitis syndrome (FPIES) is a non-Immunoglobulin (non-IgE)-mediated food allergy. The elimination diet is the only therapy, the culprit food will be reintroduced if tolerance is acquired. However, it is possible that patients do not follow the recommendations given by the healthcare professional. We investigated if our advice to avoid the trigger food in patients with active FPIES and to reintroduce it in the diet in patients who achieved tolerance had been implemented. We interviewed by telephone the parents of children who were diagnosed with acute FPIES. About 23.2% of our patients disregarded our dietary recommendations: 6/42 (14.3%) of patients who passed a tolerance oral food challenge (OFC) did not eat the trigger food, 4/22 (18.2%) of patients who failed OFC ate the trigger food, and 9/18 (50.0%) of patients who did not perform a tolerance OFC ate the trigger food. We have analyzed some possible influencing factors and no difference was found to be statistically significant. Our results are in line with those reported for IgE-mediated food allergies. As has already been proposed by others, we suggest reassessing food consumption in all patients after a food challenge.
Identifiants
pubmed: 36203511
doi: 10.1002/ped4.12333
pii: PED412333
pmc: PMC9523800
doi:
Types de publication
Journal Article
Langues
eng
Pagination
207-210Informations de copyright
© 2022 Chinese Medical Association. Pediatric Investigation published by John Wiley & Sons Australia, Ltd on behalf of Futang Research Center of Pediatric Development.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Ann Allergy Asthma Immunol. 2021 Jul;127(1):28-35
pubmed: 33757808
Pediatr Allergy Immunol. 2021 Jul;32(5):1066-1072
pubmed: 33621373
Expert Rev Clin Immunol. 2013 Aug;9(8):707-15
pubmed: 23971749
J Allergy Clin Immunol Pract. 2020 May;8(5):1702-1709
pubmed: 32004746
J Allergy Clin Immunol. 2020 May;145(5):1430-1437.e11
pubmed: 31940468
Allergy. 2010 Jun 1;65(6):797-8
pubmed: 19886919
Pediatr Allergy Immunol. 2006 Dec;17(8):601-5
pubmed: 17121588
Allergol Immunopathol (Madr). 2016 Jan-Feb;44(1):54-8
pubmed: 26242568
J Allergy Clin Immunol. 2017 Apr;139(4):1111-1126.e4
pubmed: 28167094